Asthma as a risk factor and allergic rhinitis as a protective factor for COVID-19 severity: a case-control study.
Martha Débora Lira TenórioGabriel Valentim Dos Santos Menezes SiqueiraGustavo Costa CaldasRoque Pacheco de AlmeidaAmélia Ribeiro de JesusPaulo Ricardo Saquete Martins FilhoPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)
This study underscores the divergent effects of chronic inflammatory airway diseases on COVID-19 severity, with asthma associated with a higher likelihood of severe outcomes and rhinitis potentially offering protective effects. These findings enhance our understanding of the complex interactions between respiratory allergies and COVID-19, emphasizing the importance of targeted clinical management and public health strategies.